Who Paid My Doc
Ultravate
Drug Dermatology
NDC 10631-122-04
General payments
$271,717
Research payments
$32,254
Through program year 2023, $271,717 in general payments and $32,254 in research payments were reported against Ultravate (Dermatology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $75 | 3 |
| 2022 | General | $45 | 2 |
| 2021 | General | $159,149 | 7,063 |
| 2020 | General | $89,099 | 721 |
| 2020 | Research | $4,756 | 1 |
| 2019 | General | $23,349 | 1,419 |
| 2019 | Research | $27,498 | 6 |
Breakdown
Each share is of general payments naming this product in 2023.
Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2023 where a state was reported.
Records
9,208 general · 7 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.